Feng Y - Search Results

1

Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.

She C, Wu C, Guo W, Xie Y, Li S, Liu W, Xu C, Li H, Cao P, Yang Y, Wang X, Chang A, Feng Y, Hao J. She C, et al. Among authors: feng y. J Exp Clin Cancer Res. 2023 Sep 11;42(1):238. doi: 10.1186/s13046-023-02814-x. J Exp Clin Cancer Res. 2023. PMID: 37697370 Free PMC article.

2

mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A.

Zhao L, Su H, Liu X, Wang H, Feng Y, Wang Y, Chen H, Dai L, Lai S, Xu S, Li C, Hao J, Tang B. Zhao L, et al. Among authors: feng y. Cell Biosci. 2022 Nov 12;12(1):183. doi: 10.1186/s13578-022-00919-y. Cell Biosci. 2022. PMID: 36371321 Free PMC article.

3

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.

Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B. Jia G, et al. Among authors: feng y. J Exp Clin Cancer Res. 2023 Mar 2;42(1):54. doi: 10.1186/s13046-023-02626-z. J Exp Clin Cancer Res. 2023. PMID: 36864449 Free PMC article. No abstract available.

4

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.

Fu D, Yan J, Zhang Z, Liu Y, Ma X, Ding J, Yang S, Zhao R, Chang A, Gao C, Liu J, Zhao T, Wang X, Huang C, Gao S, Ma Y, Tang B, Feng Y, Wang H, Hao J. Fu D, et al. Among authors: feng y. Cancer Biol Med. 2023 Jun 27;20(8):599-626. doi: 10.20892/j.issn.2095-3941.2023.0039. Cancer Biol Med. 2023. PMID: 37381714 Free PMC article.

5

Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma.

Sun H, Ge Y, Liu J, Li Z, Li H, Zhao T, Wang X, Feng Y, Wang H, Gao S, Shi L, Yang S, Sun P, Chang A, Hao J, Huang C. Sun H, et al. Among authors: feng y. Oncogene. 2024 Mar;43(11):776-788. doi: 10.1038/s41388-024-02938-0. Epub 2024 Jan 20. Oncogene. 2024. PMID: 38243080

6

BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism.

Sun H, Li H, Guan Y, Yuan Y, Xu C, Fu D, Xie P, Li J, Zhao T, Wang X, Feng Y, Wang H, Gao S, Yang S, Shi Y, Liu J, Chang A, Huang C, Hao J. Sun H, et al. Among authors: feng y. Sci Adv. 2024 Jun 21;10(25):eadj8650. doi: 10.1126/sciadv.adj8650. Epub 2024 Jun 19. Sci Adv. 2024. PMID: 38896624 Free PMC article.

7

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.

Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H. Wang Y, et al. Among authors: feng y. Signal Transduct Target Ther. 2023 Dec 10;8(1):449. doi: 10.1038/s41392-023-01720-0. Signal Transduct Target Ther. 2023. PMID: 38072908 Free PMC article. Review.

8

Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer.

Wang Y, Hu J, Fleishman JS, Li Y, Ren Z, Wang J, Feng Y, Chen J, Wang H. Wang Y, et al. Among authors: feng y. Front Pharmacol. 2024 May 23;15:1290183. doi: 10.3389/fphar.2024.1290183. eCollection 2024. Front Pharmacol. 2024. PMID: 38855750 Free PMC article. Review.

9

Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study.

Tang XF, Li QX, Han YL, Wang XZ, Song Y, Zhang Z, Xu JJ, Liu ZY, Chen Y, Zhang YZ, Zhu P, Guo XG, Jiang L, Wang ZF, Liu R, Wang QS, Yao Y, Feng YQ, Zhao XY, Yuan JQ. Tang XF, et al. Among authors: feng yq. Heliyon. 2024 Oct 23;10(22):e39748. doi: 10.1016/j.heliyon.2024.e39748. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39584103 Free PMC article.

10

Operative Times in Scleral Buckle Surgery: Influencing Factors and Cost Analysis.

Blumenthal J, Meshkin RS, Hoyek S, Feng Y, Patel NA. Blumenthal J, et al. Among authors: feng y. J Vitreoretin Dis. 2024 Nov 22:24741264241293904. doi: 10.1177/24741264241293904. Online ahead of print. J Vitreoretin Dis. 2024. PMID: 39583984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,314 results

Search Page

Filters